Cargando…
Role of Prolactin Receptors in Lymphangioleiomyomatosis
Pulmonary lymphangioleiomyomatosis (LAM) is a rare lung disease caused by mutations in the tumor suppressor genes encoding Tuberous Sclerosis Complex (TSC) 1 and TSC2. The protein product of the TSC2 gene is a well-known suppressor of the mTOR pathway. Emerging evidence suggests that the pituitary h...
Autores principales: | Alkharusi, Amira, Lesma, Elena, Ancona, Silvia, Chiaramonte, Eloisa, Nyström, Thomas, Gorio, Alfredo, Norstedt, Gunnar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713116/ https://www.ncbi.nlm.nih.gov/pubmed/26765535 http://dx.doi.org/10.1371/journal.pone.0146653 |
Ejemplares similares
-
Anti-EGFR Antibody Reduces Lung Nodules by Inhibition of EGFR-Pathway in a Model of Lymphangioleiomyomatosis
por: Lesma, Elena, et al.
Publicado: (2015) -
MON-LB054 Activity of Prolactin Receptor Antagonist-Rapamycin Conjugate in Glioblastoma Multiform
por: Alkharusi, Amira, et al.
Publicado: (2019) -
An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation
por: Yu, Shengze, et al.
Publicado: (2019) -
Stimulation of prolactin receptor induces STAT-5 phosphorylation and cellular invasion in glioblastoma multiforme
por: Alkharusi, Amira, et al.
Publicado: (2016) -
Human Cytomegalovirus Infection Induces High Expression of Prolactin and Prolactin Receptors in Ovarian Cancer
por: Rahbar, Afsar, et al.
Publicado: (2020)